z-logo
Premium
A one‐step automated synthesis of the dopamine transporter ligand [ 18 F]FECNT from the chlorinated precursor
Author(s) -
PijarowskaKruszyna Justyna,
Jaron Antoni,
Kachniarz Artur,
Malkowski Bogdan,
Garnuszek Piotr,
Mikolajczak Renata
Publication year - 2016
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.3375
Subject(s) - chemistry , radiosynthesis , yield (engineering) , dopamine transporter , ligand (biochemistry) , radiochemistry , nucleophile , chemical synthesis , nucleophilic substitution , specific activity , biodistribution , nuclear chemistry , medicinal chemistry , transporter , organic chemistry , nuclear medicine , catalysis , in vitro , positron emission tomography , medicine , biochemistry , materials science , receptor , gene , metallurgy , enzyme
The use of [ 18 F]labelled nortropane derivative 2 β ‐carbomethoxy‐3 β ‐(4‐chlorophenyl)‐8‐(2‐fluoroethyl)‐nortropane (FECNT) as a dopamine transporter ligand for PET imaging is dependent on efficient radiosynthesis method. Herein, the automated synthesis of [ 18 F]FECNT from its chlorinated precursor in commercially available SynChrom [ 18 F] R&D module has been developed. The synthesis unit was readily configured for the one‐step synthesis from corresponding chlorinated precursor. The radiolabeling process involved a classical [ 18 F]fluoride nucleophilic substitution performed at 110 °C for 12 min and finally HPLC and SPE purification. Crude [ 18 F]FECNT was obtained with a radiolabeling yield of 59 ± 12% ( n  = 5). The average uncorrected amount of [ 18 F]FECNT in the final formulated dose was 2.0 ± 0.5 GBq (32 ± 7% overall decay‐corrected yields) obtained with radiochemical purity over 99% and specific activity of 55 GBq/µmol. The total duration of the procedure was 80–90 min. An automated radiosynthesis of [ 18 F]FECNT with high radiochemical purity may provide a simple and robust method of radiopharmaceutical preparation for routine clinical applications.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom